Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013)

Ani Pharmaceuticals (ANIP) reported Cash from Discontinued Operations of 44000.0 for Q4 2013, up 157.83% on a YoY basis from 17065.4 in Q4 2012, and up 118.75% sequentially from 234624.0 in Q3 2013.

Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends

Ani Pharmaceuticals (ANIP) has 2 years of Cash from Discontinued Operations data on file, last reported at 44000.0 in Q4 2013.

  • For the quarter ending Q4 2013, Cash from Discontinued Operations rose 157.83% year-over-year to 44000.0; the trailing twelve-month figure through Dec 2014 stood at 266707.0 (up 5.45% YoY), and the FY2013 full-year result was 195000.0, down 37.32% from the prior year.
  • Cash from Discontinued Operations rose to 44000.0 in Q4 2013, from 234624.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 44000.0 in Q4 2013 to a low of 234624.0 in Q3 2013.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Ani Pharmaceuticals 1.64 Bn 1.33 Bn 143.88 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 44,000.00
Dec 31, 2013 44,000.00
Sep 30, 2013 -234,624.00
Sep 30, 2013 -234,624.00
Dec 31, 2012 -76,083.00
Dec 31, 2012 -76,083.00
Sep 30, 2012 -15,363.00
Sep 30, 2012 -15,363.00